Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma
Clinical trial NCT03615404 · COMPLETED
Trial details
- NCT number
- NCT03615404
- Sponsor
- Gary Archer Ph.D.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-05
- Primary completion
- 2019-11-19
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.